Literature DB >> 26282491

Structurally related ganoderic acids induce apoptosis in human cervical cancer HeLa cells: Involvement of oxidative stress and antioxidant protective system.

Ru-Ming Liu1, Ying-Bo Li2, Xiang-Feng Liang2, Hui-Zhou Liu2, Jian-Hui Xiao3, Jian-Jiang Zhong4.   

Abstract

Ganoderic acids (GAs) produced by Ganoderma lucidum possess anticancer activities with the generation of reactive oxygen species (ROS). However, the role of oxidative stress in apoptotic process induced by GAs is still undefined. In this study, the effects of four structurally related GAs, i.e. GA-T, GA-Mk, and two deacetylated derivatives of GA-T (GA-T1 and GA-T2) on the antioxidant defense system and induced apoptosis in cervical cancer cells HeLa were investigated in vitro. Our results indicated that the tested GAs (5-40 μM) induced apoptotic cell death through mitochondrial membrane potential decrease and activation of caspase-9 and caspase-3. Furthermore, GAs increased the generation of intracellular ROS and attenuated antioxidant defense system by decreasing glutathione (GSH) level, superoxide dismutase (SOD) and glutathione peroxidase (GPX) activities. The above effects were remarkably blocked by the exogenous antioxidants, i.e. N-acetylcysteine, catalase and diphenyleneiodonium chloride. The potency of the four GAs toward induced apoptosis, generation of ROS and suppression of antioxidant defense system was in the order of: GA-T > GA-Mk ≈ GA-T1 > GA-T2 in HeLa cells. These findings suggest that GAs induced mitochondria-dependent cell apoptosis in HeLa cells are mediated via enhancing oxidative stress and depressing antioxidant defense. Additionally, the acetylation of hydroxyl groups in GAs may contribute to their pro-oxidant activities and cytotoxicity, which is helpful to the development of novel chemotherapy agents.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acetylation; Antioxidant defense system; Cell apoptosis; Ganoderic acid; Ganoderma lucidum; Reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 26282491     DOI: 10.1016/j.cbi.2015.08.005

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  7 in total

1.  Chemical composition, antiproliferative and antioxidant activity of differently processed Ganoderma lucidum ethanol extracts.

Authors:  Sonja Veljović; Mile Veljović; Ninoslav Nikićević; Saša Despotović; Siniša Radulović; Miomir Nikšić; Lana Filipović
Journal:  J Food Sci Technol       Date:  2017-03-10       Impact factor: 2.701

2.  FPOA induces the apoptosis of HepG2 cells.

Authors:  Mingjie Song; Haiying Bao; Tolgor Bau
Journal:  Exp Ther Med       Date:  2018-01-08       Impact factor: 2.447

Review 3.  Mycomedicine: A Unique Class of Natural Products with Potent Anti-tumour Bioactivities.

Authors:  Rongchen Dai; Mengfan Liu; Wan Najbah Nik Nabil; Zhichao Xi; Hongxi Xu
Journal:  Molecules       Date:  2021-02-19       Impact factor: 4.411

Review 4.  Traditional uses, chemical components and pharmacological activities of the genus Ganoderma P. Karst.: a review.

Authors:  Li Wang; Jie-Qing Li; Ji Zhang; Zhi-Min Li; Hong-Gao Liu; Yuan-Zhong Wang
Journal:  RSC Adv       Date:  2020-11-18       Impact factor: 4.036

5.  Extract of Ganoderma sinensis spores induces cell cycle arrest of hepatoma cell via endoplasmic reticulum stress.

Authors:  Weiming Lin; Li Gu; Ling-Yan Zhu; Sha Zhou; Danhong Lian; Yongquan Xu; Limin Zheng; Xin Liu; Lian Li
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 6.  Emerging Roles of Ganoderma Lucidum in Anti-Aging.

Authors:  Jue Wang; Bin Cao; Haiping Zhao; Juan Feng
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

7.  Antitumor Activity of Extract From the Sporoderm-Breaking Spore of Ganoderma lucidum: Restoration on Exhausted Cytotoxic T Cell With Gut Microbiota Remodeling.

Authors:  Jiyan Su; Lu Su; Dan Li; Ou Shuai; Yifan Zhang; Huijia Liang; Chunwei Jiao; Zhanchi Xu; Yong Lai; Yizhen Xie
Journal:  Front Immunol       Date:  2018-07-31       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.